Get the Stockscreener App
6.005
13.95%
0.735
After Hours:
6.12
0.115
+1.92%
Lixte Biotechnology Holdings Inc stock is traded at $6.005, with a volume of 326.56K.
It is up +13.95% in the last 24 hours and up +23.81% over the past month.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
See More
Previous Close:
$5.27
Open:
$5.11
24h Volume:
326.56K
Relative Volume:
0.16
Market Cap:
$27.39M
Revenue:
-
Net Income/Loss:
$-4.69M
P/E Ratio:
-2.5773
EPS:
-2.33
Net Cash Flow:
$-3.81M
1W Performance:
+31.40%
1M Performance:
+23.81%
6M Performance:
+440.99%
1Y Performance:
+200.25%
1-Day Range:
$5.10
$6.26
1-Week Range:
$4.28
$6.26
52-Week Range:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Name
Lixte Biotechnology Holdings Inc
Sector
Industry
Phone
310 203 2902
Address
248 ROUTE 25A, EAST SETAUKET
Compare LIXT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
6.005 | 22.62M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News
LIXTE Biotechnology makes $2.6M initial purchase of digital currency - MSN
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock is a must watch in 2025July 2025 Update & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What indicators show strength in Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - Newser
Ranking Lixte Biotechnology Holdings Inc. among high performing stocks via toolsMarket Activity Recap & Real-Time Market Trend Scan - Newser
How to interpret RSI for Lixte Biotechnology Holdings Inc. Equity Warrant stock2025 Key Highlights & Weekly High Return Stock Opportunities - Newser
What’s next for Lixte Biotechnology Holdings Inc. stock price2025 Big Picture & Daily Stock Trend Watchlist - Newser
Applying chart zones and confluence areas to Lixte Biotechnology Holdings Inc.Market Trend Report & AI Driven Price Forecasts - Newser
Using AI based signals to follow Lixte Biotechnology Holdings Inc. Equity WarrantEarnings Recap Summary & Growth Focused Investment Plans - Newser
Understanding Lixte Biotechnology Holdings Inc.’s price movementJuly 2025 Recap & Verified Chart Pattern Trade Signals - Newser
Will Lixte Biotechnology Holdings Inc. stock recover after recent dropTrade Analysis Summary & Real-Time Buy Zone Alerts - Newser
Short interest data insights for Lixte Biotechnology Holdings Inc.Quarterly Trade Summary & Risk Managed Investment Signals - Newser
Lixte Biotechnology Holdings Inc. Equity Warrant’s volatility index tracking explainedEntry Point & Low Risk High Win Rate Picks - Newser
What the charts say about Lixte Biotechnology Holdings Inc. todayWall Street Watch & Free Daily Entry Point Trade Alerts - Newser
What’s next for Lixte Biotechnology Holdings Inc. Equity Warrant stock priceTrade Volume Report & Risk Controlled Stock Pick Alerts - Newser
Can technical indicators confirm Lixte Biotechnology Holdings Inc.’s reversal - Newser
Long term hold vs stop loss in Lixte Biotechnology Holdings Inc.Options Play & Expert-Curated Trade Recommendations - Newser
Multi asset correlation models including Lixte Biotechnology Holdings Inc.Weekly Investment Summary & High Conviction Buy Zone Alerts - Newser
Historical volatility pattern of Lixte Biotechnology Holdings Inc. visualized2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
ranking lixte biotechnology holdings inc. equity warrant among high performing stocks via toolsJuly 2025 WrapUp & Accurate Trade Setup Notifications - Newser
What institutional flow reveals about Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Update & High Yield Stock Recommendations - Newser
Applying sector rotation models to Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
Lixte Biotechnology Invests $2.6M in Cryptocurrencies - TipRanks
Lixte Biotechnology Holdings Inc. Equity Warrant stock trend forecastWeekly Trade Report & Safe Capital Growth Plans - Newser
How to manage a losing position in Lixte Biotechnology Holdings Inc.Portfolio Return Summary & Short-Term Trading Alerts - Newser
How high can Lixte Biotechnology Holdings Inc. stock go2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Risk adjusted return profile for Lixte Biotechnology Holdings Inc. analyzedJuly 2025 Patterns & Weekly High Momentum Picks - Newser
LIXTE Biotechnology Holdings, Inc. Announces Strategic Purchase of Cryptocurrencies to Diversify Treasury Holdings - Quiver Quantitative
LIXTE Biotechnology Holdings Makes $2.6 Million Initial - GlobeNewswire
$2.6M Crypto Investment: Biotech LIXTE Allocates 43.6% Treasury to Bitcoin and Ethereum Holdings - Stock Titan
What candlestick patterns are forming on Lixte Biotechnology Holdings Inc.Weekly Trend Recap & Technical Pattern Based Signals - Newser
What moving averages say about Lixte Biotechnology Holdings Inc. Equity WarrantGDP Growth & Safe Capital Growth Plans - Newser
Has Lixte Biotechnology Holdings Inc. formed a bullish divergenceJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
Trend Reversal Possible in Lixte Biotechnology Holdings Inc. Charts Indicate2025 Risk Factors & Capital Efficiency Focused Ideas - beatles.ru
Published on: 2025-09-08 13:24:20 - beatles.ru
Is Lixte Biotechnology Holdings Inc. forming a bullish divergence2025 Big Picture & Free Community Supported Trade Ideas - beatles.ru
Certain Common Stock of Lixte Biotechnology Holdings, Inc. are subject to a Lock-Up Agreement Ending on 7-SEP-2025. - MarketScreener
Certain Options of Lixte Biotechnology Holdings, Inc. are subject to a Lock-Up Agreement Ending on 7-SEP-2025. - MarketScreener
Certain Warrants of Lixte Biotechnology Holdings, Inc. are subject to a Lock-Up Agreement Ending on 7-SEP-2025. - MarketScreener
Key resistance and support levels for Lixte Biotechnology Holdings Inc. Equity Warrant2025 Market Outlook & Verified Swing Trading Watchlist - Newser
Aug Closing: Will Lixte Biotechnology Holdings Inc. stock hit new highs in YEARJuly 2025 Highlights & Reliable Volume Spike Alerts - خودرو بانک
Can Lixte Biotechnology Holdings Inc. Equity Warrant sustain its profitabilityWeekly Investment Recap & Risk Controlled Stock Alerts - خودرو بانک
Lixte Biotechnology Holdings Inc. stock trend outlook and recovery pathTrade Entry Report & Long-Term Investment Growth Plans - Newser
Does Lixte Biotechnology Holdings Inc. meet Warren Buffett’s criteriaEarnings Growth Report & Step-by-Step Trade Execution Guides - خودرو بانک
Institutional Tools Highlight Unusual Flow in Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Chart Watch & High Accuracy Investment Signals - beatles.ru
Does Lixte Biotechnology Holdings Inc. have declining or rising EPSDay Trade & Verified Chart Pattern Trade Signals - خودرو بانک
Using economic indicators to assess Lixte Biotechnology Holdings Inc. Equity Warrant potentialBond Market & Fast Entry and Exit Trade Plans - Newser
Is Lixte Biotechnology Holdings Inc. still a buy after recent gainsWeekly Trade Review & Free Risk Controlled Daily Trade Plans - خودرو بانک
Is Lixte Biotechnology Holdings Inc. stock entering bullish territoryJuly 2025 Technicals & Community Supported Trade Ideas - Newser
Tools to assess Lixte Biotechnology Holdings Inc. Equity Warrant’s risk profile2025 Market Outlook & Risk Managed Investment Signals - Newser
Is Lixte Biotechnology Holdings Inc. Equity Warrant benefiting from interest rate changesJuly 2025 Snapshot & Stock Portfolio Risk Management - خودرو بانک
What moving averages say about Lixte Biotechnology Holdings Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):